The repair of alkylation damage to the genome is critical in all cells, because such damage is cytotoxic and potentially mutagenic. These repair pathways counteract endogenous and environmental alkylating agents. Alkylation chemotherapy is a major therapeutic modality for many tumors, underscoring the importance of these pathways in cancer. A number of different pathways exist for alkylation repair, which include base excision and nucleotide excision repair, direct reversal by methyl-guanine methyltransferase (MGMT), and dealkylation by the AlkB protein family. We recently demonstrated that one of the human AlkB homologues, ALKBH3, plays an important role in alkylation damage repair in specific tumor cells, but is dispensable for this function in nonmalignant cells. This suggests that alkylation repair enzymes may be differentially regulated in various cellular contexts. While much is known about the biochemical mechanisms that mediate DNA alkylation repair, we know very little about how these pathways are modulated, particularly in metazoans. We have recently discovered a critical role for the deubiquitinase OTUD4 in the regulation of MGMT and the AlkB family of enzymes in human cells. Our data suggests that OTUD4 functions as a component of a complex with multiple, differentially regulated deubiquitinase activities to control alkylation repair, as well as impacting DNA damage signaling. Together, our work implicates ubiquitination as a critical regulator of alkylation damage repair, an unexplored area which we seek to understand in this proposal. Specifically, we will test the hypothesis that OTUD4 serves as a deubiquitinase complex scaffold that promotes alkylation chemoresistance, both in vitro and in a mouse tumor model (Aim 1). We will also determine how the catalytic specificity of this deubiquitinase may be regulated by post- translational modification to modulate DNA damage response signaling (Aim 2). Finally, we will test the hypothesis that non-proteasomal ubiquitination plays a role in the activation of the ALKBH3 pathway (Aim 3). Beyond its implications on our understanding of DNA repair pathways, this work will provide new insights into tumor responses to alkylation chemotherapy, and may reveal novel small molecule targets for chemo sensitization.

Public Health Relevance

The research proposed in this grant has significance for the way in which cells guard their genomes, a pathway important for cancer development as well as cancer treatment. The proposed studies will shed light on the molecular mechanisms in this pathway, and may lead to novel diagnostic and therapeutic avenues in cancer.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Cancer Etiology Study Section (CE)
Program Officer
Okano, Paul
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Washington University
Schools of Medicine
Saint Louis
United States
Zip Code
Zhao, Yu; Mudge, Miranda C; Soll, Jennifer M et al. (2018) OTUD4 Is a Phospho-Activated K63 Deubiquitinase that Regulates MyD88-Dependent Signaling. Mol Cell 69:505-516.e5
Theisen, Derek J; Davidson 4th, Jesse T; Briseño, Carlos G et al. (2018) WDFY4 is required for cross-presentation in response to viral and tumor antigens. Science 362:694-699
Hung, Putzer J; Johnson, Britney; Chen, Bo-Ruei et al. (2018) MRI Is a DNA Damage Response Adaptor during Classical Non-homologous End Joining. Mol Cell 71:332-342.e8
Soll, Jennifer M; Brickner, Joshua R; Mudge, Miranda C et al. (2018) RNA ligase-like domain in activating signal cointegrator 1 complex subunit 1 (ASCC1) regulates ASCC complex function during alkylation damage. J Biol Chem 293:13524-13533
Soll, Jennifer M; Sobol, Robert W; Mosammaparast, Nima (2017) Regulation of DNA Alkylation Damage Repair: Lessons and Therapeutic Opportunities. Trends Biochem Sci 42:206-218
Brickner, Joshua R; Soll, Jennifer M; Lombardi, Patrick M et al. (2017) A ubiquitin-dependent signalling axis specific for ALKBH-mediated DNA dealkylation repair. Nature 551:389-393
Lemaçon, Delphine; Jackson, Jessica; Quinet, Annabel et al. (2017) MRE11 and EXO1 nucleases degrade reversed forks and elicit MUS81-dependent fork rescue in BRCA2-deficient cells. Nat Commun 8:860
Zhao, Yu; Majid, Mona C; Soll, Jennifer M et al. (2015) Noncanonical regulation of alkylation damage resistance by the OTUD4 deubiquitinase. EMBO J 34:1687-703